Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-016123
Filing Date
2025-02-21
Accepted
2025-02-21 16:03:26
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B5 tm257266-1_424b5.htm 424B5 433852
2 EX-FILING FEES tm257266d1_ex-filingfees.htm   iXBRL EX-FILING FEES 17806
3 GRAPHIC lg_amicustherape-4c.jpg GRAPHIC 46473
  Complete submission text file 0001104659-25-016123.txt   647053

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT tm257266d1_ex-filingfees_htm.xml XML 4568
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-285059 | Film No.: 25651634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)